SBIR/STTR Research Award
Highly Scalable Multiplexed CRISPR Technologies for Medical, Industrial, and Agricultural Applications
Award amount
$1,459,755Program and phase
SBIR · Phase IIAward year
2018Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Advanced Research Projects Agency
- Recipient company
- De Novo DNA
- Proposal award date
- 2018-09-18
- Contract end date
- 2020-10-17
- UEI
- FQUMSWDTHE29
- Solicitation number
- 16.3
- Topic code
- SB163-003
Research abstract
We propose to create transformative technologies to overcome several CRISPR-wide challenges that will broadly enable scalable, multiplexable gene editing & gene regulation with minimal off-target activity. Our technical solutions combine computational design of optimal CRISPR components, genetic circuits, and RNPs together with experimental validation. We will implement several demonstrative applications to exemplify how these technologies fundamentally transform CRISPR from a 1-guide, 1-unique site tool to a many-guide, many-gene platform with many thousands of potential industrial, medical, and agricultural applications.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.